ATI-2231
202306048
Phase 1 small_molecule terminated
Quick answer
ATI-2231 for Advanced Solid Tumor is a Phase 1 program (small_molecule) at Aclaris Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aclaris Therapeutics
- Indication
- Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated